期刊文献+

血清IGF-1及CEA、CYFRA21-1检测联合18F-FDGPET/CT在肺癌诊断和复发监测中的价值研究

The Comparative Study of Diagnostic Value of Serum IGF-1,CEA and CYFRA21-1 Combined with 18F-FDG PET/CT on Lung Cancer
下载PDF
导出
摘要 目的评价和比较血清IGF-1及CEA、CYFRA21。1联合检测、氟.18-氟代脱氧葡萄糖18F-FDG)PET/CT及IGF.1联合18F.FDGPET/CT~种方法早期诊断肺癌的临床价值。方法对确诊的18例肺癌患者和1例肺良性病变患者行PET-CT扫描并行血清学IGF.1、CEA和CYFRA21.检测,比较IGF.1+CEA+CYFRA21.1、PET/CT、IGF。1+PET/CT三种方法对肺癌的检出率。结果IGF-1+cEA+cYFRA2l-1组合对肺癌诊断的灵敏度、准确率和假阴性率分别为83.3%(15/18)、78.9%(15/19)和16.7%(3/18);18F—FDGPET/CT显像分别为88.9%(16/18)、89.5%(17/19)和11.1%(2/18);IGF.1+18F.FDGPET/CT组合分别为88.9%(16/18)、89.5%(17/19)和11.1%(2/18)。结论IGF-1+CEA+CYFRA21.1可作为一种很好的筛查肺癌方法;PET/CT显像对肺癌的诊断有较高的价值;IGF-1与PET/CT联合不能提高诊断肺癌的效能。 Objective To evaluate the diagnostic value of IGF-1 combined with serum tumor markers CEA and CYFRA21-l,positron emission tomography/computed tomography with fluorine-18-labeled fluoredeoxyglucose(lSF-FDG PET/CT),and IGF-1 combined with 18F-FDG PET/CT on lung cancer.Method 18F-FDG PET/CT scan was performed in 18 lung cancer patients diagnosed and 1 patients with benign pulmonary disease.The serum levels of IGF-1,CEA and CYFRA21-1 were detected in the same persons.The sensitivity, accuracy and false positive rate of the combination of IGF- 1,CEA with CYFRA21-1,PET/CT and the combination of IGF-1 with PET/CT were analyzed.Results The sensitivity, accuracy and false positive rate of the combination of IGF-1 with serum tumor markers CEA and CYFRA21-1 was 83.3%(15/18),78.9%(15/19) and 16.7%(3/18),respectively;and those of PET-CT scan was 88.9%(16/18),89.5%(17/19) and 11.1%(2/18),respectively;those of the combination of IGF- 1 with PET/CT scan was 88.9%(16/18),89.5 %(17/19) and 11.1%(2~18),respectively.Conclusion The combination of IGF-1 with serum tumor markers CEA and CYFRA21-1 was an effective screening method on lung cancer.PET/CT was of great value for the diagnosis of lung cancer;Combination of IGF-1 with PET/CT scan cannot enhance significantly diagnostic efficiency on lung cancer.
出处 《中国血液流变学杂志》 CAS 2012年第4期707-709,共3页 Chinese Journal of Hemorheology
关键词 肺癌 IGF-1 CEA CYFRA21—1 PET CT lung cancer IGF- 1 CEA CYFRA21-1 positron emission tomography/computed tomography
  • 相关文献

参考文献4

  • 1Douglas JB,Silverman DT,Pollak MN. Serum IGF-Ⅰ,IGF-Ⅱ,IGFBP-3,and IGF-Ⅰ/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate,lung,colorectal,and ovarian cancer screening trial[J].Cancer Epidemiology Biomarkers and Prevention,2010,(09):2298-2306.
  • 2Gualberto A,Hixon ML,Karp DD. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab[J].British Journal of Cancer,2011,(01):68-74.
  • 3Jeong SY,Lee KS,Shin KM. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules[J].Lung Cancer,2008,(02):186-194.
  • 4Lardinois D,Weder W,Hany TF. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography[J].New England Journal of Medicine,2003,(25):2500-2507.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部